CAPMH


Open Access Highly Access

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies

Peter M Wehmeier*, Ralf W Dittmann, Alexander Schacht, Karin Helsberg and Gerd Lehmkuhl

Child and Adolescent Psychiatry and Mental Health 2009, 3:5 doi:10.1186/1753-2000-3-5

Accesses  

  • Last 30 days: 168 accesses
  • Last 365 days: 1679 accesses
  • All time: 4852 accesses

Cited by

BioMed Central: 1 citation

Methodology   Open Access

A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): Rationale and design

Tracey W Tsang, Michael R Kohn, Daniel F Hermens, Simon D Clarke, C Richard Clark, Daryl Efron, Noel Cranswick, Chris Lamb, Leanne M Williams Trials 2011, 12:77 (13 March 2011)